N/A 2986055Recalls & reported problems
Medtronic Sofamor Danek, Inc. · INSTRUMENT 2986055 10 X 55 MM DSTRCTR TR · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00613994236531), received between Mar 21, 2020 and Mar 21, 2020 — classified as 1 injury.
The most frequently reported specific device problem is “Malposition of Device” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Malposition of Device1
Patient problems
- Blood Loss1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryMar 21, 2020Malposition of Device; Malposition of Device
IT WAS REPORTED THAT THE PATIENT PRESENTED WITH DEGENERATIVE KYPHOSIS; AND UNDERWENT OBLIQUE LUMBAR INTERBODY FUSION AT L4-L5. INTRA-OP, AFTER TRIAL WAS INSERTED, BLEEDING AMOUNT INCREASED. BY CHECKING SAGITTAL IMAGE, IT WAS FOUND THAT THE POSITION OF THE TRIAL WAS ON THE ANTERIOR SIDE VERY MUCH. HEMOSTASIS WAS PERFORMED USING FLOSEAL AND AVITENE. THE CAGE INSERTION WAS COMPLETED WHILE PERFORMING HEMOSTASIS CAREFULLY. THE BLEEDING AMOUNT WAS ABOUT 1800CC. THE CAUSE OF THE BLEEDING COULD NOT BE IDENTIFIED, BUT IT WAS CONSIDERED THAT THERE WAS ALSO A POSSIBILITY THAT BLEEDING OCCURRED DURING THE REMOVAL OF THE INTERVERTEBRAL DISC OR DURING DEALING WITH THE VERTEBRAL ENDPLATE. ACCORDING TO THE DOCTOR, EXTERNAL ILIAC VEINS MAY HAVE RUPTURED. THERE WAS A DELAY OF LESS THAN 60 MINUTES IN THE OVERALL PROCEDURE TIME. IT WAS UNKNOWN HOW MUCH THE PATIENT ISSUE WAS RESOLVED; BUT A POSTERIOR OPERATION FROM T10-S2 WAS SCHEDULED FOR (B)(6) 2020. ON (B)(6) 2020, A TWO-STAGE SURGERY, POSTERIOR FIXATION AT T9-S2 WAS PERFORMED. POSTERIOR LUMBAR INTERBODY FUSION WAS PERFORMED AT L5/S1 AND OSTEOTOMY WAS PERFORMED AT L3. PLIF AT L5-S1 WAS PERFORMED, FOLLOWED BY SCREW INSERTION, FOLLOWED BY OSTEOTOMY AT
Patient problems: Blood Loss
MAUDE report 9863432 ↗
Other Intervertebral fusion device with bone graft, lumbar devices
- T-PAL 03.812.003Synthes GmbH · Intervertebral fusion device with bone graft, lumbar152 reports
- T-PAL 03.812.004Synthes GmbH · Intervertebral fusion device with bone graft, lumbar120 reports
- Catalyft PL Expandable Interbody System 6068073Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall66 reports
- Catalyft PL Expandable Interbody System 6069076Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall51 reports
- Catalyft PL Expandable Interbody System 6068076Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall46 reports
- EIT TLIF Inserter TFT30101EIT Emerging Implant Technologies GmbH · Intervertebral Fusion Device With Bone Graft, Lumbar88 reports
- T-PAL 03.812.001Synthes GmbH · Intervertebral fusion device with bone graft, lumbar76 reports
- Catalyft PL Expandable Interbody System 6069096Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall25 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page